Recruiting Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) NCT05660083 Conditions Breast Diseases, Breast Neoplasms, HER2-negative Breast Cancer, +8 more Locations National Institute of Health Clinical Center — Bethesda, Maryland, United States Houston Methodist Neal Cancer Center — Houston, Texas, United States The University of Texas MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
Recruiting Agnostic Therapy in Rare Solid Tumors NCT06638931 Conditions Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more Locations Hospital São Carlos — Fortaleza, Ceará, Brazil Hospital São Rafael — Salvador, Estado de Bahia, Brazil Hospital Santa Cruz — Curitiba, Paraná, Brazil IDOR Recife — Recife, Pernambuco, Brazil View more locations Show fewer locations Loading locations... View Trial Details
